Eli Lilly last week announced the results of a Phase 3 trial on its experimental drug called Donanemab. The latest drug trial in a new class of Alzheimer’s drugs gives researchers and advocates renewed hope of slowing the progression of the brain disease.

Subscribe to FOX 9 Minneapolis-St. Paul [ Ссылка ]

Watch FOX 9 Live: [ Ссылка ]

FOX 9 is your source for breaking news, live events, investigations, politics, entertainment, business news and local stories from Minneapolis-St. Paul, the greater Twin Cities metro, Greater Minnesota, western Wisconsin and across the nation. FOX 9 is the Official Home of the Minnesota Vikings and proud partner of University of Minnesota Golden Gophers Athletics.

Download the FOX 9 News app: [ Ссылка ]

Download the Weather app
Google Play: [ Ссылка ]
App Store: [ Ссылка ]

Follow FOX 9 on Facebook: [ Ссылка ]

Follow FOX 9 on Twitter: [ Ссылка ]

Follow FOX 9 on Instagram: [ Ссылка ]

Subscribe to the FOX 9 newsletter: [ Ссылка ]

свернуть